Insider · CIK 0001852018

CONKLING WILLIAM

Reports to the SEC for 4 companies · NEWARK, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001852018

Forms 4 and 5

Insider transactions

33 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-09	IDTIDT CORPA Award	Director	AAward	+673 sh	$55.75	+$37.5K	673
2026-06-02	TARAProtara Therapeutics, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−6,008 sh	$4.34	−$26.1K	69,992
2026-01-16	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+158K sh	—	—	158,000
2026-01-16	TARAProtara Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+26K sh	—	—	76,000
2025-06-02	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Commercial Officer	AAward	+200K sh	—	—	200,000
2025-06-02	TARAProtara Therapeutics, Inc.A Award	Chief Commercial Officer	AAward	+50K sh	—	—	50,000
2025-03-25	RFLRafael Holdings, Inc. · Employee Stock Option (right to buy)A Award	Chief Executive Officer	AAward	+2,362 sh	—	—	2,362
2025-03-25	RFLRafael Holdings, Inc.A Award	Chief Executive Officer	AAward	+27.5K sh	—	—	564,455
2025-03-25	RFLRafael Holdings, Inc. · Employee Stock Option (right to buy)A Award	Chief Executive Officer	AAward	+5,485 sh	—	—	5,485
2025-03-21	RFLRafael Holdings, Inc.F Tax Payment	Chief Executive Officer	FTax Payment	−14.8K sh	$1.93	−$28.6K	537,001
2025-02-27	Cyclo Therapeutics, Inc.A Award	Director	AAward	+27.7K sh	—	—	77,884
2025-01-13	RFLRafael Holdings, Inc.A Award	Chief Executive Officer	AAward	+60K sh	$1.95	+$117K	551,815
2024-12-21	RFLRafael Holdings, Inc.F Tax Payment	Chief Executive Officer	FTax Payment	−12.8K sh	$1.83	−$23.5K	491,815
2024-11-15	Cyclo Therapeutics, Inc.A Award	Director	AAward	+16.7K sh	—	—	50,230
2024-10-25	RFLRafael Holdings, Inc.F Tax Payment	Chief Executive Officer	FTax Payment	−3,431 sh	$1.84	−$6,313.04	504,622
2024-09-21	RFLRafael Holdings, Inc.F Tax Payment	Chief Executive Officer	FTax Payment	−12.7K sh	$1.73	−$21.9K	508,053
2024-08-16	Cyclo Therapeutics, Inc.A Award	Director	AAward	+8,731 sh	—	—	33,570
2024-06-21	RFLRafael Holdings, Inc.F Tax Payment	Chief Executive Officer	FTax Payment	−13.3K sh	$1.46	−$19.3K	520,749
2024-06-03	Cyclo Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15.6K sh	—	—	15,562
2024-06-03	Cyclo Therapeutics, Inc.A Award	Director	AAward	+8,594 sh	—	—	24,839
2024-03-21	RFLRafael Holdings, Inc.F Tax Payment	Chief Executive Officer	FTax Payment	+15.5K sh	$1.71	+$26.4K	534,044
2024-02-13	Cyclo Therapeutics, Inc.A Award	Director	AAward	+6,330 sh	—	—	16,245
2023-12-21	RFLRafael Holdings, Inc.F Tax Payment	Chief Executive Officer	FTax Payment	+13.6K sh	$1.82	+$24.8K	549,517
2023-11-28	Cyclo Therapeutics, Inc.A Award	Director	AAward	+7,466 sh	—	—	9,915
2023-10-25	RFLRafael Holdings, Inc.A Award	Chief Executive Officer	AAward	+40K sh	$1.51	+$60.6K	563,119
2023-09-21	RFLRafael Holdings, Inc.F Tax Payment	Chief Executive Officer	FTax Payment	−13.7K sh	$2.21	−$30.1K	523,119
2023-08-18	Cyclo Therapeutics, Inc.A Award	Director	AAward	+2,449 sh	—	—	2,449
2023-06-21	RFLRafael Holdings, Inc.F Tax Payment	Chief Executive Officer	FTax Payment	−15.2K sh	$2.15	−$32.6K	536,788
2023-06-06	Cyclo Therapeutics, Inc.Stock Option (Right to buy)A Award	Director	AAward	+6,700 sh	—	—	6,700
2023-03-21	RFLRafael Holdings, Inc.F Tax Payment	Chief Executive Officer	FTax Payment	−15.6K sh	$1.67	−$26.1K	551,958
2022-12-21	RFLRafael Holdings, Inc.F Tax Payment	Chief Executive Officer	FTax Payment	−56.1K sh	$1.76	−$98.8K	567,583
2022-02-01	RFLRafael Holdings, Inc.A Award	Chief Executive Officer	AAward	+624K sh	—	—	623,732
2021-04-15	RFLRafael Holdings, Inc. · Employee Stock Option (right to buy)A Award	Chief Executive Officer	AAward	+118K sh	—	—	118,409

Recent filings

Accepted (ET)
Jun 114
CONKLING WILLIAM0001193125-26-267388
SEC(opens sec.gov)
Jun 34
CONKLING WILLIAM0001213900-26-064792
SEC(opens sec.gov)
Jan 214
CONKLING WILLIAM0001213900-26-006231
SEC(opens sec.gov)
Jun 44
CONKLING WILLIAM0001213900-25-051157
SEC(opens sec.gov)
Apr 244
CONKLING WILLIAM0000950170-25-057934
SEC(opens sec.gov)
Mar 254
CONKLING WILLIAM0000950170-25-044469
SEC(opens sec.gov)
Mar 34
CONKLING WILLIAM0001437749-25-005852
SEC(opens sec.gov)
Jan 154
CONKLING WILLIAM0000950170-25-005759
SEC(opens sec.gov)
Dec 234
CONKLING WILLIAM0000950170-24-139519
SEC(opens sec.gov)
Nov 184
CONKLING WILLIAM0001437749-24-035589
SEC(opens sec.gov)
Oct 294
CONKLING WILLIAM0000950170-24-118362
SEC(opens sec.gov)
Sep 244
CONKLING WILLIAM0000950170-24-108970
SEC(opens sec.gov)
Aug 204
CONKLING WILLIAM0001437749-24-027331
SEC(opens sec.gov)
Jun 254
CONKLING WILLIAM0000950170-24-077206
SEC(opens sec.gov)
Jun 54
CONKLING WILLIAM0001437749-24-019341
SEC(opens sec.gov)

Companies

Address

C/O IDT CORPORATION 520 BROAD STREET

NEWARK, NJ, 07102